Sahaj Hospitals Profile
Key Indicators
- Authorised Capital ₹ 4.90 M
as on 16-11-2024
- Paid Up Capital ₹ 4.90 M
as on 16-11-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 16-11-2024
- Revenue -5.46%
(FY 2023)
- Profit 18.05%
(FY 2023)
- Ebitda 15.46%
(FY 2023)
- Net Worth 20.48%
(FY 2023)
- Total Assets 16.96%
(FY 2023)
About Sahaj Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.90 M and a paid-up capital of Rs 4.90 M.
The company currently has active open charges totaling ₹1.50 Cr.
Sulochana Bohara, Rajendra Sharma, and Priti Jain serve as directors at the Company.
- CIN/LLPIN
U85110MP2008PTC021050
- Company No.
021050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sahaj Hospitals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sulochana Bohara | Director | 12-Nov-2014 | Current |
Rajendra Sharma | Director | 01-Apr-2015 | Current |
Priti Jain | Director | 19-Aug-2008 | Current |
Financial Performance of Sahaj Hospitals.
Sahaj Hospitals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.46% decrease. The company also saw a substantial improvement in profitability, with a 18.05% increase in profit. The company's net worth Soared by an impressive increase of 20.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sahaj Hospitals?
In 2023, Sahaj Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sahaj Innovative Cell Therapy Private LimitedActive 9 years 7 months
Sulochana Bohara and Priti Jain are mutual person
- Sahaj Regenerative Cell Therapeutics Private LimitedActive 11 months 7 days
Sulochana Bohara and Priti Jain are mutual person
- Hope Diagnostic And Fertility Centre Private LimitedActive 22 years 1 month
Priti Jain is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 11 Dec 2019 | ₹7.50 M | Open |
Others Creation Date: 25 Sep 2017 | ₹7.50 M | Open |
How Many Employees Work at Sahaj Hospitals?
Sahaj Hospitals has a workforce of 28 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahaj Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahaj Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.